Suguru Ishizaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suguru Ishizaka has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Tada
Departments of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
1 shared publication - Hiroyuki Aoyagi
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Hokkaido, Japan
1 shared publication Hisao Nishino
Diagnostic Center for Sonography, Hokkaido University Hospital, Sapporo, Japan
1 shared publication- Kazunori Omote
Department of Cardiology, Hokkaido Cardiovascular Hospital, Sapporo, Japan
1 shared publication Keita Sakaguchi
Graduate School of Health Sciences, Hokkaido University, Sapporo, Japan
1 shared publication- Kiwamu Kamiya
Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
1 shared publication
Latest Publications
- 24 December 2024
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (3) , 219-221
Role of anatomical regurgitant orifice area of the tricuspid valve measurements in patients with beyond severe tricuspid regurgitation
- 24 December 2024
- Published by Springer Nature in Journal of Echocardiography
- Vol. 23 (3) , 219-221
Role of anatomical regurgitant orifice area of the tricuspid valve measurements in patients with beyond severe tricuspid regurgitation
- Open Access
- 1 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (23) , 7459
Exercise Capacity and Clinical Outcomes in Chronic Heart Failure Patients with Mild Tricuspid Regurgitation
Aim: The present study aimed to investigate the impact of mild tricuspid regurgitation (TR) on the exercise capacity or clinical outcomes in patients with chronic heart failure (CHF). Methods and Results: The study enrolled 511 patients with CHF who underwent cardiopulmonary exercise testing (CPET) between 2013 and 2018. The primary outcome was a composite of heart failure hospitalization and death. Patients with mild TR (n = 324) or significant TR (moderate or greater; n = 60) displayed worse NHYA class and reduced exercise capacity on CPET than those with non-TR (n = 127), but these were more severely impaired in patients with significant TR. A total of 90 patients experienced events over a median follow-up period of 3.3 (interquartile range 0.8–5.5) years. Patients with significant TR displayed a higher risk of events, while patients with mild TR had a 3.0-fold higher risk of events than patients with non-TR (hazard ratio (HR) 3.01; 95% confidence interval (CI), 1.50–6.07). Multivariate Cox regression analysis showed that, compared with non-TR, mild TR was associated with increased adverse events, even after adjustment for co-variates (HR 2.97; 95% CI, 1.35–6.55). Conclusions: TR severity was associated with worse symptoms, reduced exercise capacity, and poor clinical outcomes. Even patients with mild TR had worse clinical characteristics than those with non-TR.
- 1 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (23) , 7459
Open AccessExercise Capacity and Clinical Outcomes in Chronic Heart Failure Patients with Mild Tricuspid Regurgitation
Aim: The present study aimed to investigate the impact of mild tricuspid regurgitation (TR) on the exercise capacity or clinical outcomes in patients with chronic heart failure (CHF). Methods and Results: The study enrolled 511 patients with CHF who underwent cardiopulmonary exercise testing (CPET) between 2013 and 2018. The primary outcome was a composite of heart failure hospitalization and death. Patients with mild TR (n = 324) or significant TR (moderate or greater; n = 60) displayed worse NHYA class and reduced exercise capacity on CPET than those with non-TR (n = 127), but these were more severely impaired in patients with significant TR. A total of 90 patients experienced events over a median follow-up period of 3.3 (interquartile range 0.8–5.5) years. Patients with significant TR displayed a higher risk of events, while patients with mild TR had a 3.0-fold higher risk of events than patients with non-TR (hazard ratio (HR) 3.01; 95% confidence interval (CI), 1.50–6.07). Multivariate Cox regression analysis showed that, compared with non-TR, mild TR was associated with increased adverse events, even after adjustment for co-variates (HR 2.97; 95% CI, 1.35–6.55). Conclusions: TR severity was associated with worse symptoms, reduced exercise capacity, and poor clinical outcomes. Even patients with mild TR had worse clinical characteristics than those with non-TR.